IL205300A0 - Sdf-1 based glycosaminoglycan antogonists and uses thereof - Google Patents

Sdf-1 based glycosaminoglycan antogonists and uses thereof

Info

Publication number
IL205300A0
IL205300A0 IL205300A IL20530010A IL205300A0 IL 205300 A0 IL205300 A0 IL 205300A0 IL 205300 A IL205300 A IL 205300A IL 20530010 A IL20530010 A IL 20530010A IL 205300 A0 IL205300 A0 IL 205300A0
Authority
IL
Israel
Prior art keywords
antogonists
sdf
glycosaminoglycan
based glycosaminoglycan
glycosaminoglycan antogonists
Prior art date
Application number
IL205300A
Other languages
English (en)
Original Assignee
Protaffin Biotechnologie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protaffin Biotechnologie Ag filed Critical Protaffin Biotechnologie Ag
Publication of IL205300A0 publication Critical patent/IL205300A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL205300A 2007-10-24 2010-04-22 Sdf-1 based glycosaminoglycan antogonists and uses thereof IL205300A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07450189A EP2053060A1 (en) 2007-10-24 2007-10-24 SDF-1-based glyocosaminoglycan antagonists and methods of using same
PCT/EP2008/008960 WO2009053064A1 (en) 2007-10-24 2008-10-23 Sdf-1-based glycosaminoglycan antagonists and methods of using same

Publications (1)

Publication Number Publication Date
IL205300A0 true IL205300A0 (en) 2010-12-30

Family

ID=39133777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205300A IL205300A0 (en) 2007-10-24 2010-04-22 Sdf-1 based glycosaminoglycan antogonists and uses thereof

Country Status (13)

Country Link
US (1) US20100298203A1 (enExample)
EP (2) EP2053060A1 (enExample)
JP (1) JP2011501675A (enExample)
KR (1) KR20100085041A (enExample)
CN (1) CN101835800A (enExample)
AU (1) AU2008315614A1 (enExample)
BR (1) BRPI0818009A2 (enExample)
CA (1) CA2702502A1 (enExample)
EA (1) EA201000688A1 (enExample)
IL (1) IL205300A0 (enExample)
MX (1) MX2010004025A (enExample)
NZ (1) NZ584278A (enExample)
WO (1) WO2009053064A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201200470A1 (ru) * 2009-09-11 2012-08-30 Протаффин Биотехнологие Аг Композиция для лечения опосредуемого cxcl8 воспаления легкого
CN102094043B (zh) * 2010-11-23 2012-11-07 山东农业大学 猪趋化因子cxcl12基因及其应用
EP2686344A1 (en) 2011-03-16 2014-01-22 Protaffin Biotechnologie AG Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same
WO2013007704A2 (en) 2011-07-08 2013-01-17 Protaffin Biotechnologie Ag Novel sdf-1-based glycosaminoglycan antagonist and methods of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364894A (en) * 1993-03-31 1994-11-15 Tremco, Inc. Emulsification of asphalt and modified asphalt with primary emulsifier polymers comprised of acrylic acid type monomers
JP2000507596A (ja) * 1996-04-02 2000-06-20 プロジェニクス・ファーマスーティカルス・インコーポレーテッド Ｃｄ４▲上＋▼細胞のｈｉｖ―１感染を防ぐ方法
AU5811001A (en) * 2000-05-09 2001-11-20 Univ British Columbia Cxcr4 antagonist treatment of hematopoietic cells
WO2004094465A2 (en) * 2003-04-23 2004-11-04 The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign Synthetic molecules that mimic chemokines
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
US7662221B2 (en) * 2006-06-23 2010-02-16 Johns Manville Spray applied building wrap coating material, spray applied building wrap, and building construction assembly
AT504685B1 (de) * 2006-12-20 2009-01-15 Protaffin Biotechnologie Ag Fusionsproteine

Also Published As

Publication number Publication date
WO2009053064A8 (en) 2009-07-16
CN101835800A (zh) 2010-09-15
JP2011501675A (ja) 2011-01-13
BRPI0818009A2 (pt) 2015-04-14
MX2010004025A (es) 2010-04-30
EP2053060A1 (en) 2009-04-29
NZ584278A (en) 2012-06-29
EA201000688A1 (ru) 2010-10-29
US20100298203A1 (en) 2010-11-25
AU2008315614A1 (en) 2009-04-30
CA2702502A1 (en) 2009-04-30
EP2203473A1 (en) 2010-07-07
WO2009053064A1 (en) 2009-04-30
KR20100085041A (ko) 2010-07-28

Similar Documents

Publication Publication Date Title
TWI561237B (en) Substituted dihydropyrazolones and their use
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
ZA200810323B (en) Fkbp-l and uses thereof
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
IL201018A0 (en) Novel asparaginases and uses thereof
LT2064327T (lt) Dbait ir jų panaudojimas
ZA200807544B (en) Pseudoinfectious flavivirus and uses thereof
ZA201001300B (en) Antigen-asjuvant compositions and methods
IL180998A0 (en) Modular construction units and uses thereof
ZA200903906B (en) Carboranylporphyrins and uses thereof
GB0721291D0 (en) Methods and compositions
IL205577A0 (en) Anti-factor b antibodies and their uses
GB0719526D0 (en) Compositions and methods
IL205300A0 (en) Sdf-1 based glycosaminoglycan antogonists and uses thereof
EP2097446A4 (en) RESISTANT ANTAGONISTS AND ITS USE
GB0715428D0 (en) Compositions and uses thereof
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
ZA201001402B (en) Mouse and stay thereof
GB0701170D0 (en) Compositions and uses thereof
SI2032708T1 (sl) Rekombinantni novirabdovirusi in njihove uporabe
IL206104A0 (en) Aminothiazoles and their uses
GB0701171D0 (en) Compositions and uses thereof
GB0707069D0 (en) Methods and uses
GB0813359D0 (en) Halfin and/or platerfin
GB0725264D0 (en) Compositions and uses thereof